Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations

İpek Özcan, Erkan Azizoğlu, Taner Şenyiğit, Mine Özyazıcı, Özgen ÖzerEge University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Bornova, Izmir, TurkeyAbstract: The objective of this study was to prepare a suitable formulation for...

Full description

Bibliographic Details
Main Authors: Özcan İ, Azizoğlu E, Şenyiğit T, Özyazıcı M, Özer Ö
Format: Article
Language:English
Published: Dove Medical Press 2013-01-01
Series:International Journal of Nanomedicine
Online Access:http://www.dovepress.com/enhanced-dermal-delivery-of-diflucortolone-valerate-using-lecithinchit-a12082
_version_ 1818570755183476736
author Özcan İ
Azizoğlu E
Şenyiğit T
Özyazıcı M
Özer Ö
author_facet Özcan İ
Azizoğlu E
Şenyiğit T
Özyazıcı M
Özer Ö
author_sort Özcan İ
collection DOAJ
description İpek Özcan, Erkan Azizoğlu, Taner Şenyiğit, Mine Özyazıcı, Özgen ÖzerEge University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Bornova, Izmir, TurkeyAbstract: The objective of this study was to prepare a suitable formulation for dermal delivery of diflucortolone valerate (DFV) that would maintain the localization in skin layers without any penetration and to optimize efficiency of DFV. Drug-loaded lecithin/chitosan nanoparticles with high entrapment efficiency (86.8%), were successfully prepared by ionic interaction technique. Sustained release of DFV was achieved without any initial burst release. Nanoparticles were also incorporated into chitosan gel at different ratios for preparing a more suitable formulation for topical drug delivery with adequate viscosity. In ex-vivo permeation studies, nanoparticles increased the accumulation of DFV especially in the stratum corneum + epidermis of rat skin without any significant permeation. Retention of DFV from nanoparticle in chitosan gel formulation (0.01%) was twofold higher than commercial cream, although it contained ten times less DFV. Nanoparticles in gel formulations produced significantly higher edema inhibition in rats compared with commercial cream in in-vivo studies. Skin blanching assay using a chromameter showed vasoconstriction similar to that of the commercial product. There were no barrier function changes upon application of nanoparticles. In-vitro and in-vivo results demonstrated that lecithin/chitosan nanoparticles in chitosan gel may be a promising carrier for dermal delivery of DFV in various skin disorders.Keywords: skin permeation, anti-inflammatory activity, skin blanching, TEWL
first_indexed 2024-12-14T13:46:05Z
format Article
id doaj.art-4a1c4cdf070a489ea4ec5b4a07660cda
institution Directory Open Access Journal
issn 1176-9114
1178-2013
language English
last_indexed 2024-12-14T13:46:05Z
publishDate 2013-01-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-4a1c4cdf070a489ea4ec5b4a07660cda2022-12-21T22:59:19ZengDove Medical PressInternational Journal of Nanomedicine1176-91141178-20132013-01-012013default461475Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluationsÖzcan İAzizoğlu EŞenyiğit TÖzyazıcı MÖzer Öİpek Özcan, Erkan Azizoğlu, Taner Şenyiğit, Mine Özyazıcı, Özgen ÖzerEge University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Bornova, Izmir, TurkeyAbstract: The objective of this study was to prepare a suitable formulation for dermal delivery of diflucortolone valerate (DFV) that would maintain the localization in skin layers without any penetration and to optimize efficiency of DFV. Drug-loaded lecithin/chitosan nanoparticles with high entrapment efficiency (86.8%), were successfully prepared by ionic interaction technique. Sustained release of DFV was achieved without any initial burst release. Nanoparticles were also incorporated into chitosan gel at different ratios for preparing a more suitable formulation for topical drug delivery with adequate viscosity. In ex-vivo permeation studies, nanoparticles increased the accumulation of DFV especially in the stratum corneum + epidermis of rat skin without any significant permeation. Retention of DFV from nanoparticle in chitosan gel formulation (0.01%) was twofold higher than commercial cream, although it contained ten times less DFV. Nanoparticles in gel formulations produced significantly higher edema inhibition in rats compared with commercial cream in in-vivo studies. Skin blanching assay using a chromameter showed vasoconstriction similar to that of the commercial product. There were no barrier function changes upon application of nanoparticles. In-vitro and in-vivo results demonstrated that lecithin/chitosan nanoparticles in chitosan gel may be a promising carrier for dermal delivery of DFV in various skin disorders.Keywords: skin permeation, anti-inflammatory activity, skin blanching, TEWLhttp://www.dovepress.com/enhanced-dermal-delivery-of-diflucortolone-valerate-using-lecithinchit-a12082
spellingShingle Özcan İ
Azizoğlu E
Şenyiğit T
Özyazıcı M
Özer Ö
Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
International Journal of Nanomedicine
title Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_full Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_fullStr Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_full_unstemmed Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_short Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_sort enhanced dermal delivery of diflucortolone valerate using lecithin chitosan nanoparticles in vitro and in vivo evaluations
url http://www.dovepress.com/enhanced-dermal-delivery-of-diflucortolone-valerate-using-lecithinchit-a12082
work_keys_str_mv AT ampoumlzcani enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
AT azizoglue enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
AT senyigitt enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
AT ampoumlzyazıcım enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
AT ampoumlzerampouml enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations